Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biorestorative Therapies Inc

+ Add to Watchlist


0.4000 USD 0.00000.00%

As of 20:10:00 ET on 03/30/2015.

Snapshot for Biorestorative Therapies Inc (BRTX)

Open: 0.3500 Day's Range: 0.3500 - 0.4000 Volume: 2,860
Previous Close: 0.4000 52wk Range: 0.2400 - 0.6000 1-Yr Rtn: -9.09%

Stock Chart for BRTX

No chart data available.
  • BRTX:US 0.4000
  • 1D
  • 1M
  • 1Y
Interactive BRTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BRTX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 12.58
Shares Outstanding (M) 31.46
30 Day Average Volume 21,459
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BRTX

No data available

Company Profile & Key Executives for BRTX

Biorestorative Therapies Inc develops medical procedures using adult stem cells (non-embryonic) allowing patients to undergo minimally invasive cellular-based treatments. The Company is developing technology that involves the use of adult stem cells to treat bulging and herniated discs and a brown fat stem cell-based program focusing on treatments for metabolic disorders and obesity.

Mark WeinrebPresident/CEOEdward L Field "Ed"PRES:brtxDISC
Mandy D ClarkVP:Operations/SecretaryFrancisco J SilvaVP:Research & Development
More Company Profile & Key Executives for BRTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil